Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Synergistic effects of deleting multiple nonessential elements in nonreplicative HSV-1 BAC genomic vectors play a critical role in their viability

Gene Therapy volume 24, pages 433–440 (2017)Cite this article

Subjects

Abstract

Nonreplicative Herpes simplex virus type-1 (HSV-1) genomic vectors have already entered into clinical trials for neurological gene therapy thanks to their scalable growth in permissive cells. However, the small transgene capacity of this type of HSV-1 vectors currently used in the clinic represents an important limiting factor as a gene delivery system. To develop high-capacity nonreplicative genomic HSV-1 vectors, in this study we have characterized a series of multiply deleted mutants which we have constructed in bacterial artificial chromosomes (BACs), removing up to 24 kb of unstable or dispensable genomic sequences to allow insertion of transgenes up to this size. We show that synergistic effects of deletions of: the HSV-1 replication origins oriS and oriL, the HSV-1 internal repeat region, the remaining ICP4 gene copy and the genes encoding for ICP27, UL56, UL55, can severely reduce the growth of these HSV-1 vectors. Given that several of these elements have been characterized as ‘non-essential’ for viral growth in cell culture by single-deletion experiments of wild-type HSV-1, our study highlights the need to re-evaluate their functional contribution in the context of multiply deleted nonreplicative HSV-1 genomic vectors. Our BAC mutants described here can serve as useful starting platforms to accelerate HSV-1 vector development.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Spaete RR, Frenkel N . The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell 1982; 30: 295–304.

    Article  CAS  Google Scholar 

  2. Roizman B . The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc Natl Acad Sci USA 1996; 93: 11307–11312.

    Article  CAS  Google Scholar 

  3. Gaffney DF, McLauchlan J, Whitton JL, Clements JB . A modular system for the assay of transcription regulatory signals: the sequence TAATGARAT is required for herpes simplex virus immediate early gene activation. Nucleic Acids Res 1985; 13: 7847–7863.

    Article  CAS  Google Scholar 

  4. Mackem S, Roizman B . Differentiation between alpha promoter and regulator regions of herpes simplex virus 1: the functional domains and sequence of a movable alpha regulator. Proc Natl Acad Sci USA 1982; 79: 4917–4921.

    Article  CAS  Google Scholar 

  5. Honess RW, Roizman B . Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol 1974; 14: 8–19.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Everett RD . Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J 1984; 3: 3135–3141.

    Article  CAS  Google Scholar 

  7. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995; 375: 411–415.

    Article  CAS  Google Scholar 

  8. Watson RJ, Clements JB . A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature 1980; 285: 329–330.

    Article  CAS  Google Scholar 

  9. Samaniego LA, Webb AL, DeLuca NA . Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4. J Virol 1995; 69: 5705–5715.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Wu N, Watkins SC, Schaffer PA, DeLuca NA . Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol 1996; 70: 6358–6369.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Samaniego LA, Neiderhiser L, DeLuca NA . Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol 1998; 72: 3307–3320.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Krisky DM, Wolfe D, Goins WF, Marconi PC, Ramakrishnan R, Mata M et al. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther 1998; 5: 1593–1603.

    Article  CAS  Google Scholar 

  13. Fink DJ, Wechuck J, Mata M, Glorioso JC, Goss J, Krisky D et al. Gene therapy for pain: results of a phase I clinical trial. Ann Neurol 2011; 70: 207–212.

    Article  CAS  Google Scholar 

  14. Khalique H, Lopez Marco J, Lim F . A haploid HSV-1 genome platform for vector development: testing of the tetracycline-responsive switch shows interference by infected cell protein 0. J Gene Med 2016; 18: 302–311.

    Article  CAS  Google Scholar 

  15. Brown SM, Harland J, Subak-Sharpe JH . Isolation of restriction endonuclease site deletion mutants of herpes simplex virus. J Gen Virol 1984; 65 (Pt 6): 1053–1068.

    Article  CAS  Google Scholar 

  16. Jenkins FJ, Donoghue AM, Martin JR . Deletion of the Herpes simplex 1 internal repeat sequences affects pathogenicity in the mouse. Front Biosci 1996; 1: a59–a68.

    Article  CAS  Google Scholar 

  17. Poffenberger KL, Tabares E, Roizman B . Characterization of a viable, noninverting herpes simplex virus 1 genome derived by insertion and deletion of sequences at the junction of components L and S. Proc Natl Acad Sci USA 1983; 80: 2690–2694.

    Article  CAS  Google Scholar 

  18. Nash TC, Spivack JG . The UL55 and UL56 genes of herpes simplex virus type 1 are not required for viral replication, intraperitoneal virulence, or establishment of latency in mice. Virology 1994; 204: 794–798.

    Article  CAS  Google Scholar 

  19. Smith IL, Sekulovich RE, Hardwicke MA, Sandri-Goldin RM . Mutations in the activation region of herpes simplex virus regulatory protein ICP27 can be trans dominant. J Virol 1991; 65: 3656–3666.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Igarashi K, Fawl R, Roller RJ, Roizman B . Construction and properties of a recombinant herpes simplex virus 1 lacking both S-component origins of DNA synthesis. J Virol 1993; 67: 2123–2132.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. DeLuca NA, Schaffer PA . Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res 1987; 15: 4491–4511.

    Article  CAS  Google Scholar 

  22. Weller SK, Spadaro A, Schaffer JE, Murray AW, Maxam AM, Schaffer PA . Cloning, sequencing, and functional analysis of oriL, a herpes simplex virus type 1 origin of DNA synthesis. Mol Cell Biol 1985; 5: 930–942.

    Article  CAS  Google Scholar 

  23. Post LE, Roizman B . A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth. Cell 1981; 25: 227–232.

    Article  CAS  Google Scholar 

  24. Sears AE, Halliburton IW, Meignier B, Silver S, Roizman B . Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice. J Virol 1985; 55: 338–346.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J . Gene therapy clinical trials worldwide to 2012 - an update. J Gene Med 2013; 15: 65–77.

    Article  CAS  Google Scholar 

  26. Craft AM, Krisky DM, Wechuck JB, Lobenhofer EK, Jiang Y, Wolfe DP et al. Herpes simplex virus-mediated expression of Pax3 and MyoD in embryoid bodies results in lineage-Related alterations in gene expression profiles. Stem Cells 2008; 26: 3119–3129.

    Article  CAS  Google Scholar 

  27. Miyagawa Y, Marino P, Verlengia G, Uchida H, Goins WF, Yokota S et al. Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity. Proc Natl Acad Sci USA 2015; 112: E1632–E1641.

    Article  CAS  Google Scholar 

  28. Summers BC, Leib DA . Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters. J Virol 2002; 76: 7020–7029.

    Article  CAS  Google Scholar 

  29. Earley E, Peralta PH, Johnson KM . A plaque neutralization method for arboviruses. Proc Soc Exp Biol Med 1967; 125: 741–747.

    Article  CAS  Google Scholar 

  30. Eldering JA, Felten C, Veilleux CA, Potts BJ . Development of a PCR method for mycoplasma testing of Chinese hamster ovary cell cultures used in the manufacture of recombinant therapeutic proteins. Biologicals 2004; 32: 183–193.

    Article  CAS  Google Scholar 

  31. Cunningham C, Davison AJ . A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 1993; 197: 116–124.

    Article  CAS  Google Scholar 

  32. Saeki Y, Fraefel C, Ichikawa T, Breakefield XO, Chiocca EA . Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol Ther 2001; 3: 591–601.

    Article  CAS  Google Scholar 

  33. Schultze N, Burki Y, Lang Y, Certa U, Bluethmann H . Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nat Biotechnol 1996; 14: 499–503.

    Article  CAS  Google Scholar 

  34. Ejercito PM, Kieff ED, Roizman B . Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol 1968; 2: 357–364.

    Article  CAS  Google Scholar 

  35. Tanaka M, Kagawa H, Yamanashi Y, Sata T, Kawaguchi Y . Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J Virol 2003; 77: 1382–1391.

    Article  CAS  Google Scholar 

  36. Muyrers JP, Zhang Y, Stewart AF, Techniques . Recombinogenic engineering—new options for cloning and manipulating DNA. Trends Biochem Sci 2001; 26: 325–331.

    Article  CAS  Google Scholar 

  37. Muyrers JP, Zhang Y, Testa G, Stewart AF . Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res 1999; 27: 1555–1557.

    Article  CAS  Google Scholar 

  38. Zhang Y, Buchholz F, Muyrers JP, Stewart AF . A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet 1998; 20: 123–128.

    Article  CAS  Google Scholar 

  39. Wang S, Zhao Y, Leiby M, Zhu J . A new positive/negative selection scheme for precise BAC recombineering. Mol Biotechnol 2009; 42: 110–116.

    Article  CAS  Google Scholar 

  40. Bertani G . Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol 1951; 62: 293–300.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from Ataxia UK and ACAH (Catalan Association for Hereditary Ataxias). We thank Peggy Marconi (University of Ferrara, Italy) for kindly providing the 7b cells.

Author information

Authors and Affiliations

  1. Departamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain

    M Ventosa, A Ortiz-Temprano, H Khalique & F Lim

Authors
  1. M Ventosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Ortiz-Temprano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Khalique
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F Lim.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on Gene Therapy website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ventosa, M., Ortiz-Temprano, A., Khalique, H. et al. Synergistic effects of deleting multiple nonessential elements in nonreplicative HSV-1 BAC genomic vectors play a critical role in their viability. Gene Ther 24, 433–440 (2017). https://doi.org/10.1038/gt.2017.43

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2017.43

Search

Advanced search

Quick links